M
Marc Miravitlles
Researcher at Carlos III Health Institute
Publications - 721
Citations - 29821
Marc Miravitlles is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: COPD & Population. The author has an hindex of 76, co-authored 651 publications receiving 25671 citations. Previous affiliations of Marc Miravitlles include United States Department of Veterans Affairs & Autonomous University of Barcelona.
Papers
More filters
Journal ArticleDOI
Chronic obstructive pulmonary disease
TL;DR: The main cause is smoking tobacco, but other factors have been identified as mentioned in this paper, such as genetic determinants, lung growth, and environmental stimuli, which is further aggravated by exacerbations, particularly in patients with severe disease.
Journal ArticleDOI
Outcomes for COPD pharmacological trials: From lung function to biomarkers
Mario Cazzola,William MacNee,Fernando J. Martinez,Klaus F. Rabe,L. G. Franciosi,Peter J. Barnes,Vito Brusasco,PS Burge,Peter M.A. Calverley,Bartolome R. Celli,Paul W. Jones,Donald A. Mahler,Barry Make,Marc Miravitlles,Clive P. Page,Paolo Palange,David G. Parr,Massimo Pistolesi,S. I. Rennard,MP Rutten-van Mölken,Robert A. Stockley,Sean D. Sullivan,Jadwiga A. Wedzicha,Emiel F.M. Wouters +23 more
TL;DR: The American Thoracic Society/European Respiratory Society jointly created a Task Force on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform the chronic obstructive pulmonary disease research community about the possible use and limitations of current outcomes and markers.
Journal ArticleDOI
Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study.
Victor Sobradillo Peña,Marc Miravitlles,Rafael Gabriel,Carlos A. Jiménez-Ruiz,Carlos Villasante,Juan F. Masa,José Luis Viejo,L. Fernández-Fau +7 more
TL;DR: COPD is a very frequent disease in Spain, and presents significant geographic variations and a very low level of previous diagnosis and treatment, even in the most advanced cases.
Journal ArticleDOI
Epidemiology and costs of chronic obstructive pulmonary disease.
Kenneth R. Chapman,David M. Mannino,Joan B. Soriano,Paul Vermeire,A. S. Buist,Michael J. Thun,Cari J. Connell,A Jemal,Todd A. Lee,Marc Miravitlles,Sarah Aldington,Richard Beasley +11 more
TL;DR: COPD is under-diagnosed not only in its early stages, but even when lung function is severely impaired, and the message that COPD is both preventable and treatable has yet to be fully understood by most healthcare providers.
Journal ArticleDOI
Prevalence of copd in spain: impact of undiagnosed copd on quality of life and daily life activities.
Marc Miravitlles,Joan B. Soriano,Francisco García-Río,Luis Muñoz,Enric Duran-Tauleria,Guadalupe Sánchez,V. Sobradillo,Julio Ancochea +7 more
TL;DR: The prevalence of COPD in individuals between 40 and 80 years of age in Spain is 10.2% and increases with age, tobacco consumption and lower educational levels, while undiagnosed individuals with COPD already have a significant impairment in HRQL and ADL.